Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC18465761;5762;5763 chr2:178776328;178776327;178776326chr2:179641055;179641054;179641053
N2AB18465761;5762;5763 chr2:178776328;178776327;178776326chr2:179641055;179641054;179641053
N2A18465761;5762;5763 chr2:178776328;178776327;178776326chr2:179641055;179641054;179641053
N2B18005623;5624;5625 chr2:178776328;178776327;178776326chr2:179641055;179641054;179641053
Novex-118005623;5624;5625 chr2:178776328;178776327;178776326chr2:179641055;179641054;179641053
Novex-218005623;5624;5625 chr2:178776328;178776327;178776326chr2:179641055;179641054;179641053
Novex-318465761;5762;5763 chr2:178776328;178776327;178776326chr2:179641055;179641054;179641053

Information

  • RefSeq wild type amino acid: Y
  • RefSeq wild type transcript codon: TAC
  • RefSeq wild type template codon: ATG
  • Domain: Ig-9
  • Domain position: 6
  • Structural Position: 7
  • Q(SASA): 0.3512
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Y/C rs746592442 -0.313 0.427 N 0.442 0.12 0.430351802785 gnomAD-2.1.1 3.98E-06 None None None None I None 6.15E-05 0 None 0 0 None 0 None 0 0 0
Y/C rs746592442 -0.313 0.427 N 0.442 0.12 0.430351802785 gnomAD-4.0.0 1.59093E-06 None None None None I None 5.65291E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Y/A 0.2317 likely_benign 0.2694 benign -1.736 Destabilizing 0.002 N 0.347 neutral None None None None I
Y/C 0.1202 likely_benign 0.1313 benign -0.581 Destabilizing 0.427 N 0.442 neutral N 0.499307592 None None I
Y/D 0.4182 ambiguous 0.4687 ambiguous -0.795 Destabilizing 0.065 N 0.549 neutral N 0.477023038 None None I
Y/E 0.464 ambiguous 0.532 ambiguous -0.745 Destabilizing 0.018 N 0.422 neutral None None None None I
Y/F 0.0358 likely_benign 0.0355 benign -0.859 Destabilizing None N 0.091 neutral N 0.459980124 None None I
Y/G 0.417 ambiguous 0.4694 ambiguous -2.007 Highly Destabilizing 0.037 N 0.397 neutral None None None None I
Y/H 0.1587 likely_benign 0.1874 benign -0.668 Destabilizing 0.196 N 0.399 neutral N 0.416448614 None None I
Y/I 0.1128 likely_benign 0.1148 benign -0.939 Destabilizing 0.004 N 0.291 neutral None None None None I
Y/K 0.3963 ambiguous 0.4864 ambiguous -0.915 Destabilizing 0.009 N 0.365 neutral None None None None I
Y/L 0.265 likely_benign 0.277 benign -0.939 Destabilizing None N 0.165 neutral None None None None I
Y/M 0.2525 likely_benign 0.2807 benign -0.696 Destabilizing 0.044 N 0.487 neutral None None None None I
Y/N 0.191 likely_benign 0.2107 benign -1.262 Destabilizing 0.065 N 0.532 neutral N 0.417729981 None None I
Y/P 0.5226 ambiguous 0.6171 pathogenic -1.197 Destabilizing 0.22 N 0.574 neutral None None None None I
Y/Q 0.2851 likely_benign 0.3483 ambiguous -1.186 Destabilizing 0.085 N 0.469 neutral None None None None I
Y/R 0.3022 likely_benign 0.371 ambiguous -0.569 Destabilizing None N 0.252 neutral None None None None I
Y/S 0.1406 likely_benign 0.1577 benign -1.601 Destabilizing 0.028 N 0.361 neutral N 0.419833638 None None I
Y/T 0.2069 likely_benign 0.2343 benign -1.454 Destabilizing 0.018 N 0.359 neutral None None None None I
Y/V 0.1015 likely_benign 0.1067 benign -1.197 Destabilizing None N 0.172 neutral None None None None I
Y/W 0.3068 likely_benign 0.3324 benign -0.689 Destabilizing 0.245 N 0.383 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.